By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The discussion revolves around heavy long-dated call volume on MCHP and AVGO, suggesting institutional positioning for a multi-year move. However, the risk of theta decay and potential macro delays is significant, especially if industrial PMI remains weak or AI capex slows.
Risk: Theta decay and potential macro delays causing options to lose value before a margin rebound.
Opportunity: Institutional positioning for a multi-year move in MCHP and AVGO.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Microchip Technology Inc (Symbol: MCHP) options are showing a volume of 135,618 contracts thus far today. That number of contracts represents approximately 13.6 million underlying shares, working out to a sizeable 122% of MCHP's average daily trading volume over the past month, of 11.1 million shares. Particularly high volume was seen for the $75 strike call option expiring September 18, 2026, with 53,035 contracts trading so far today, representing approximately 5.3 million underlying shares of MCHP. Below is a chart showing MCHP's trailing twelve month trading history, with the $75 strike highlighted in orange:
And Broadcom Inc (Symbol: AVGO) options are showing a volume of 129,026 contracts thus far today. That number of contracts represents approximately 12.9 million underlying shares, working out to a sizeable 67.7% of AVGO's average daily trading volume over the past month, of 19.1 million shares. Particularly high volume was seen for the $430 strike call option expiring August 07, 2026, with 9,078 contracts trading so far today, representing approximately 907,800 underlying shares of AVGO. Below is a chart showing AVGO's trailing twelve month trading history, with the $430 strike highlighted in orange:
For the various different available expirations for MSFT options, MCHP options, or AVGO options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
### Further MSFT Research:
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Unusually large long-dated call volume on MCHP and AVGO points to institutional accumulation in semiconductors well beyond near-term catalysts."
Heavy call volume on MCHP's Sep-2026 $75 strike (5.3M shares, 122% of ADV) and AVGO's Aug-2026 $430 strike signals long-dated bullish conviction in semis, especially after recent sector weakness. MSFT is mentioned but lacks specifics, implying lower relevance. Current MCHP price near $75 and AVGO near $430 suggest these are at-the-money LEAPs betting on multi-year AI/analog recovery. Implied re-rating potential is material if EPS growth reaccelerates to 15-20%.
Option volume alone does not prove directional bets; much of this could be dealer gamma hedging, spread trades, or even put buyers rolling into synthetic longs. The article omits current implied volatility levels and whether these strikes are cheap or expensive on a historical basis, so enthusiasm may already be priced in.
"The heavy volume in 2026 MCHP calls indicates institutional conviction that the semiconductor inventory correction is near its terminal phase."
The massive volume in long-dated MCHP $75 calls expiring in 2026 signals institutional positioning for a cyclical recovery in the analog and microcontroller space. MCHP has been hammered by inventory corrections, but these LEAPS (Long-term Equity Anticipation Securities) suggest smart money is betting on a bottoming process. Conversely, the AVGO activity feels more like hedging or yield-enhancement strategies given its recent AI-driven run. The risk here is that the article ignores the duration of the semiconductor cycle; if industrial demand remains sluggish through 2025, these 2026 calls could decay significantly before any meaningful fundamental inflection occurs. Investors should focus on MCHP’s inventory turnover metrics rather than just option volume.
This volume may simply be a massive institutional roll of existing positions or a tax-loss harvesting strategy rather than a genuine directional bet on a recovery.
"Elevated options volume is a data point, not a forecast; without context on who's buying, expiration clustering, or IV regime, it's noise dressed as signal."
This article reports elevated options volume without explaining *why* — a critical omission. MCHP's 122% of average daily volume in calls is noteworthy, but the $75 strike (Sept 2026) sits ~8% above Friday's close, suggesting either bullish positioning or hedging ahead of earnings/product announcements. AVGO's 67.7% surge is more modest and the $430 strike is closer to current price, less directional. The real question: is this institutional accumulation (bullish signal) or dealer hedging from earlier put sales (neutral/mechanical)? Volume spikes alone don't tell us who's buying or their conviction. Without open interest trends, IV rank, or news catalysts, this reads as activity reporting masquerading as insight.
Unusually high options volume often precedes sharp reversals — dealers may be front-running forced liquidations or hedging against tail risk, not signaling insider conviction. The article's silence on *why* this happened today is deafening.
"Long-dated call activity alone is not a reliable signal of near-term upside; it may reflect hedging, volatility positioning, or multi-year bets rather than a guaranteed bullish move."
Unusually high long-dated call volume on MCHP ($75 Sep 18 2026) and AVGO ($430 Aug 7 2026) suggests more than a quick swing trade: institutions may be positioning for a multi-year move or layering in volatility/hedges. The scale vs. ADV (MCHP 122%, AVGO 67.7%) and the 2026 expiries imply bets on a broad secular driver (AI hardware demand, data-center capex) rather than a near-term catalyst. However, the article omits price action, open interest, and whether these are outright buys, spreads, or hedges. It could instead be delta hedging by market makers or a sophisticated risk-reversal. The MSFT mention adds surface-level context but no specifics on MSFT’s role.
Long-dated call volume can be a hedge or a volatility play rather than a directional bet; without price action or open interest data, these trades could unwind if IV collapses or if catalysts underwhelm.
"Without IV context and cycle timing, volume spikes risk being expensive insurance rather than conviction trades."
Claude correctly flags the missing 'why' but underplays cycle duration risk that Gemini surfaces. If industrial PMI stays below 50 through mid-2025, both 2026 LEAPs face 30-40% theta drag before any analog rebound. Option volume alone tells us nothing about positioning if IV rank is already >70th percentile; the real tell will be whether open interest builds or evaporates post-earnings.
"The MCHP options activity is likely a bet on operating margin expansion through inventory normalization rather than a simple macro-industrial recovery."
Grok and Gemini are fixated on industrial cycles, but they are ignoring the specific nature of MCHP’s recent distress: the massive inventory destocking cycle. If the $75 LEAPs are indeed directional, they aren't just betting on PMI; they are betting on a margin recovery as the 'channel stuffing' clears. Claude is right that we lack the 'why,' but if this is institutional, it’s likely a play on MCHP's operating leverage returning once revenue normalizes in late 2025.
"Destocking cycles resolve faster than the 2026 expiry suggests; early re-rating kills the LEAP thesis."
Gemini's margin-recovery thesis is sharper than PMI-watching, but conflates two timelines. MCHP's destocking clears faster than industrial capex cycles—inventory normalization could hit by Q3 2025, well before these Sept 2026 calls pay off. If margin recovery happens in 2025 and the stock re-rates then, holding 2026 LEAPs through that inflection is theta-negative. The real risk: these calls are priced for a *sustained* recovery, not a one-year pop that already happened.
"Long-dated LEAPs can decay in value via theta and macro timing risk, so volume doesn't prove directional conviction."
Claude's 'why' is valid, but the bigger miss is the risk-structure of LEAP bets: without open interest and IV data, these 2026 calls may be more about volatility carry or hedging than conviction. The real danger is theta decay and potential macro delays—if PMI remains weak or AI capex slows, these 2026 options could lose value before a margin rebound, regardless of MCHP/AVGO fundamentals.
The discussion revolves around heavy long-dated call volume on MCHP and AVGO, suggesting institutional positioning for a multi-year move. However, the risk of theta decay and potential macro delays is significant, especially if industrial PMI remains weak or AI capex slows.
Institutional positioning for a multi-year move in MCHP and AVGO.
Theta decay and potential macro delays causing options to lose value before a margin rebound.